Skip to main content

Table 1 Tumor characteristics

From: Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival

Characteristics

Frequency

Localization (n = 104)

 Descending/sigmoid colon

57.7 %

 Medium and lower rectum

22.1 %

 Ascending colon

17.3 %

 Transverse colon

2.9 %

Histology (n = 104)

 Adenocarcinoma NOS

50.0 %

 Tubular adenocarcinoma

39.4 %

 Mucin-secreting adenocarcinoma

4.8 %

 Mucinous adenocarcinoma

3.8 %

 Signet ring cell carcinoma

1.0 %

 Cribriform adenocarcinoma

1.0 %

Histologic differentiation (n = 92)

 Well (1)

6.5 %

 Moderate (2)

82.6 %

 Poor (3)

10.9 %

Blood vessel invasion (n = 81)

 Yes

16.0 %

 No

84 %

Lymphatic invasion (n = 80)

 Yes

36.3 %

 No

63.7 %

Perineural invasion (n = 78)

 Yes

30.8 %

 No

60.2 %

Depth of tumor invasion (n = 98)

 T1

2.0 %

 T2

6.1 %

 T3

75.5 %

 T4

15.3 %

 Tx

1.0 %

Lymph node metastasis (n = 98)

 N0

30.6 %

 N1

32.7 %

 N2

35.7 %

 Nx

1.0 %

Metastasis (M1) at diagnosis (n =104)

 Yes

72.8 %

 No

27.2 %

TNM staging at diagnosis (n =103)

I

1.0 %

 II

11.7 %

 III

14.6 %

 IV

72.8 %

Metastatic sites (n = 105)

 Liver

65.7 %

 Lymph nodes

25.7 %

 Lung

33.3 %

 Peritoneum

17.1 %

 Skin/subcutaneous

1.0 %

 Locoregional recidive

11.5 %

Metastasis resection (n = 105)

 Yes

58.1 %

 No

41.9 %

  1. n: number of patients with available data in each category. Tumors were staged according to the 7th Edition of the TNM Classification of Malignant Tumors. NOS: not otherwise specified